These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9989235)

  • 21. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.
    Sleat DE; Donnelly RJ; Lackland H; Liu CG; Sohar I; Pullarkat RK; Lobel P
    Science; 1997 Sep; 277(5333):1802-5. PubMed ID: 9295267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays.
    Sohar I; Lin L; Lobel P
    Clin Chem; 2000 Jul; 46(7):1005-8. PubMed ID: 10894849
    [No Abstract]   [Full Text] [Related]  

  • 23. Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2).
    Van Diggelen OP; Keulemans JL; Kleijer WJ; Thobois S; Tilikete C; Voznyi YV
    Eur J Paediatr Neurol; 2001; 5 Suppl A():189-92. PubMed ID: 11588995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal ceroid lipofuscinosis: late infantile or Jansky Bielschowsky type--re-revisited.
    Wheeler RB; Schlie M; Kominami E; Gerhard L; Goebel HH
    Acta Neuropathol; 2001 Nov; 102(5):485-8. PubMed ID: 11699562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis.
    Junaid MA; Wu G; Pullarkat RK
    J Neurochem; 2000 Jan; 74(1):287-94. PubMed ID: 10617131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis.
    Wang YL; Zeng ZY; Song XW; Hao ZF; Shi YW; Tang B; Chen SQ; Gao MM; Di W; Long YS; Yi YH; Liao WP
    Neurogenetics; 2011 Feb; 12(1):93-5. PubMed ID: 20820830
    [No Abstract]   [Full Text] [Related]  

  • 27. First-trimester diagnosis of late-infantile neuronal ceroid lipofuscinosis (LINCL) by tripeptidyl peptidase I assay and CLN2 mutation analysis.
    Kleijer WJ; van Diggelen OP; Keulemans JL; Losekoot M; Garritsen VH; Stroink H; Majoor-Krakauer D; Franken PF; Eurlings MC; Taschner PE; Los FJ; Galjaard RJ
    Prenat Diagn; 2001 Feb; 21(2):99-101. PubMed ID: 11241534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.
    Crystal RG; Sondhi D; Hackett NR; Kaminsky SM; Worgall S; Stieg P; Souweidane M; Hosain S; Heier L; Ballon D; Dinner M; Wisniewski K; Kaplitt M; Greenwald BM; Howell JD; Strybing K; Dyke J; Voss H
    Hum Gene Ther; 2004 Nov; 15(11):1131-54. PubMed ID: 15610613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
    Kopan S; Sivasubramaniam U; Warburton MJ
    Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and analysis of CLN2 variants in CHO cells: Q100R represents a polymorphism, and G389E and R447H represent loss-of-function mutations.
    Lin L; Lobel P
    Hum Mutat; 2001 Aug; 18(2):165. PubMed ID: 11462245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphological studies on CLN2.
    Goebel HH; Kominami E; Neuen-Jacob E; Wheeler RB
    Eur J Paediatr Neurol; 2001; 5 Suppl A():203-7. PubMed ID: 11588998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case 27-2002: late-onset infantile neuronal ceroid lipofuscinosis.
    McBride KL
    N Engl J Med; 2003 May; 348(21):2159. PubMed ID: 12761381
    [No Abstract]   [Full Text] [Related]  

  • 34. Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses.
    Kohan R; Noher de Halac I; Tapia Anzolini V; Cismondi A; Oller Ramírez AM; Paschini Capra A; de Kremer RD
    Clin Biochem; 2005 May; 38(5):492-4. PubMed ID: 15820783
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].
    Bukina AM; Tsvetkova IV; Semiachkina AN; Il'ina ES
    Vopr Med Khim; 2002; 48(6):594-8. PubMed ID: 12698559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.
    Warburton MJ; Bernardini F
    J Inherit Metab Dis; 2000 Mar; 23(2):145-54. PubMed ID: 10801056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL.
    Sondhi D; Peterson DA; Giannaris EL; Sanders CT; Mendez BS; De B; Rostkowski AB; Blanchard B; Bjugstad K; Sladek JR; Redmond DE; Leopold PL; Kaminsky SM; Hackett NR; Crystal RG
    Gene Ther; 2005 Nov; 12(22):1618-32. PubMed ID: 16052206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal testing for late infantile neuronal ceroid lipofuscinosis.
    Berry-Kravis E; Sleat DE; Sohar I; Meyer P; Donnelly R; Lobel P
    Ann Neurol; 2000 Feb; 47(2):254-7. PubMed ID: 10665500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases.
    Wlodawer A; Durell SR; Li M; Oyama H; Oda K; Dunn BM
    BMC Struct Biol; 2003 Nov; 3():8. PubMed ID: 14609438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2).
    Hofmann SL; Atashband A; Cho SK; Das AK; Gupta P; Lu JY
    Curr Mol Med; 2002 Aug; 2(5):423-37. PubMed ID: 12125808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.